State of the art: It’s worse than you think
Auditors and authorities regularly discuss with medical device manufacturers what constitutes the state of the art. These discussions are becoming more intense against the backdrop of the new EU regulations. Manufacturers are facing delays in approvals, unnecessary product redesign, and costly clinical investigations or clinical performance studies for in vitro diagnostic devices (IVDs).
Details